Drug Shortage Report for 0.9% SODIUM CHLORIDE INJECTION, USP

Last updated on 2018-03-01 History
Report ID 19378
Drug Identification Number 00060208
Brand name SODIUM CHLORIDE 0.9% INJ 900MG/100ML USP
Common or Proper name 0.9% Sodium Chloride Injection, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) SODIUM CHLORIDE
Strength(s) 900MG
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 50mL, 100mL
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-08-15
Actual start date 2017-08-15
Estimated end date 2018-02-28
Actual end date 2018-02-28
Shortage status Resolved
Updated date 2018-03-01
Company comments For further questions regarding this product, please contact Baxter Customer Service at 1-888-719-9955 or Medical Information at 1-855-584-1368. Customers can use the following alternate code upon their clinical judgement: JB1322P- 0.9% Sodium Chloride 250 ml
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2018-03-01 English Compare
v16 2018-02-28 French Compare
v15 2018-02-28 English Compare
v14 2017-10-13 English Compare
v13 2017-10-10 French Compare
v12 2017-10-10 English Compare
v11 2017-10-10 French Compare
v10 2017-10-10 English Compare
v9 2017-09-26 French Compare
v8 2017-09-26 English Compare
v7 2017-09-12 French Compare
v6 2017-09-12 English Compare
v5 2017-08-30 French Compare
v4 2017-08-30 English Compare
v3 2017-08-16 English Compare
v2 2017-08-15 French Compare
v1 2017-08-15 English Compare

Showing 1 to 17 of 17